Noguchi Yoshihiro, Tachi Tomoya, Yoshimura Tomoaki
Laboratory of Clinical Pharmacy, Gifu Pharmaceutical University, 1-25-4, Daigakunishi, Gifu, 501-1196, Japan.
Department of Clinical Pharmacy, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1, Tanabe-dori, Nagoya, Aichi, 467-8603, Japan.
Drug Saf. 2025 Jan;48(1):1-5. doi: 10.1007/s40264-024-01473-x. Epub 2024 Aug 17.
Spontaneous reporting systems (SRS) provide valuable data for detecting unidentified adverse events not observed in clinical trials and for conducting safety assessments that accurately reflect real-world clinical practice. With the increasing number of publications using the SRS for disproportionality analysis (DA), there is an increasing demand for a comprehensive understanding of the research limitations associated with the SRS. However, there is a lack of understanding of the caveats associated with adjusting covariates in DA of the SRS. Herein, we summarized the use of covariate adjustment and its caveats in DA. The Council for International Organizations of Medical Sciences VIII suggests considering adjustments such as stratification when they can enhance the sensitivity and/or specificity of statistical analysis. However, several database-specific and statistical caveats have been identified when adjusting for covariates derived from the SRS. Disproportionality analysis may be affected not only by reporting bias at the time of enrollment but also by sparse-data bias due to variations in the number of enrollment reports. Statistical evidence is needed to determine in which cases and to what extent sensitivity and/or specificity are affected. Nevertheless, it is important for researchers to acknowledge that certain limitations discussed in this context may be inherent and cannot be rectified. Based on this understanding, they can then make an informed decision on whether to perform a covariate adjustment.
自发报告系统(SRS)为检测临床试验中未观察到的不明不良事件以及进行准确反映真实世界临床实践的安全性评估提供了有价值的数据。随着使用SRS进行不成比例分析(DA)的出版物数量不断增加,对全面了解与SRS相关的研究局限性的需求也日益增长。然而,人们对SRS的DA中调整协变量相关的注意事项缺乏了解。在此,我们总结了协变量调整在DA中的应用及其注意事项。国际医学科学组织理事会VIII建议,当调整(如分层)能够提高统计分析的敏感性和/或特异性时,应予以考虑。然而,在对源自SRS的协变量进行调整时,已发现了一些特定于数据库和统计方面的注意事项。不成比例分析可能不仅受到入组时报告偏倚的影响,还受到由于入组报告数量差异导致的稀疏数据偏倚的影响。需要统计证据来确定在哪些情况下以及在何种程度上敏感性和/或特异性会受到影响。尽管如此,研究人员必须认识到,在此背景下讨论的某些局限性可能是固有的,无法纠正。基于这种理解,他们随后可以就是否进行协变量调整做出明智的决定。